FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:1080-1081 October 8, 1998 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Nachman, J. B. PubMed Citation

To the Editor: Nachman et al. (June 4 issue),¹ as part of the Children's Cancer Group, report the results of a trial investigating the effects of an augmented intensive regimen of post-induction chemotherapy in patients with acute lymphoblastic leukemia (ALL) who had a slow response to initial chemotherapy. Unfortunately, their definition of a high-risk population raises serious questions. The use of the proportion of blasts on the marrow smear on day 7 of induction therapy as a major risk factor is based on the results of a single prognostic study,² which included only 128 patients. According to Simon and Altman,³ . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.